**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
|----------------|--------------------------------------|----------|-----------|
| 13453-62-8 |Lead(II) perchlorate trihydrate | >95 | unlisted |
|----------------|--------------------------------------|----------|-----------|
+----------------+--------------------------------------+----------+-----------+
Text for R-phrases: see Section 16
Hazard Symbols: T O N
Risk Phrases: 20/22 33 8 61 62 50/53
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. Contact with combustible material may cause fire. May cause
harm to the unborn child. Possible risk of impaired fertility. Very
toxic to aquatic organisms, may cause long-term adverse effects in
the aquatic environment.
Potential Health Effects
Eye:
May cause eye irritation. The toxicological properties of this
material have not been fully investigated.
Skin:
May cause skin irritation. The toxicological properties of this
material have not been fully investigated.
Ingestion:
Ingestion of lead compounds can cause toxic effects in the
blood-forming organs, kidneys and central nervous system. Ingestion
of lead compounds can produce symptoms of lead poisoning. Symptoms of
lead poisoning or plumbism include weakness, weight loss, lassitude,
insomnia, and hypotension. It also includes constipation, anorexia,
abdominal discomfort and colic.
Inhalation:
May cause respiratory tract irritation. The toxicological properties
of this substance have not been fully investigated.
Chronic:
Chronic exposure to lead may result in plumbism which is
characterized by lead line in gum, headache, muscle weakness, mental
changes. Chronic expsoure to lead may cause adverse effects on human
reproduction, embryonic and fetal development and postnatal (e.g.,
mental) development.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Strong oxidizer. Contact with other material may
cause fire. Use water with caution and in flooding amounts.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Provide ventilation. Keep combustibles (wood, paper, oil,
etc.,) away from spilled material.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Keep from contact with
clothing and other combustible materials. Avoid breathing dust.
Storage:
Do not store near combustible materials. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other
engineering controls to control airborne levels below recommended
exposure limits. Facilities storing or utilizing this material should
be equipped with an eyewash facility and a safety shower.
Exposure Limits
CAS# 13453-62-8:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
CAS# 13637-76-8:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Wear a NIOSH/MSHA or European Standard EN 149
approved full-facepiece airline respirator in the
positive pressure mode with emergency escape
provisions. Refer to 29 CFR1910.1025 for regulations
on respiratory protection required during exposure to
lead and lead compounds.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 100 deg C (dec)
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature: 100 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 2.6000
Molecular Formula: PbCl2O8H6O3
Molecular Weight: 460.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Has not been fully evaluated.
Conditions to Avoid:
Dust generation.
Incompatibilities with Other Materials:
Strong reducing agents, organic matter, combustible materials.
Hazardous Decomposition Products:
Lead/lead oxides, chloride fumes.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 13453-62-8 unlisted.
CAS# 13637-76-8: SC8100000
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Lead(II) perchlorate trihydrate -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
Lead perchlorate -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: LEAD PERCHLORATE
Hazard Class: 5.1 (6.1)
UN Number: 1470
Packing Group: II
IMO
Shipping Name: LEAD PERCHLORATE
Hazard Class: 5.1 (6.1)
UN Number: 1470
Packing Group: II
RID/ADR
Shipping Name: LEAD PERCHLORATE
Hazard Class: 5.1
UN Number: 1470
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T O N
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
R 8 Contact with combustible material may cause
fire.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 17 Keep away from combustible material.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 13453-62-8: No information available.
CAS# 13637-76-8: 2
Canada
CAS# 13637-76-8 is listed on Canada's NDSL List.
CAS# 13453-62-8 is not listed on Canada's Ingredient Disclosure List.
CAS# 13637-76-8 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 13453-62-8 is not on the TSCA Inventory because it is a hydrate.
It is considered to be listed if the CAS number for the anhydrous form
is on the inventory (40CFR720.3(u)(2)).
CAS# 13637-76-8 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
Text for R-phrases from Section 2
MSDS Creation Date: 10/14/1998 Revision #3 Date: 1/07/2005
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-Amino-4-Chlorobenzothiazole, 97%
| 19952-47-7 |
|
Lead(II) perchlorate trihydrate
| 13453-62-8 |
|
Palladium(ii)acetylacetonate, 35% pd
| 14024-61-4 |
|
Ethylenediaminetetraacetic Acid, Dicalcium Salt, 94% (Titr.)
| 19709-85-4 |
|
2-Benzoyl-5-norbornene, tech., 90% mixture of endo and exo
| 6056-35-5 |
|
alpha-Toluenethiol, 99% (gc)
| 100-53-8 |
|
Acid yellow 17
| 6359-98-4 |
|
1H-pyrrole-2,5-dicarboxaldehyde, 94% (gc)
| |
|
1-Ethyl-2-pyrrolidinone, 98%
| 2687-91-4 |
|
Iodo-PDSMTSC-Iron(IV) complex
| 0-00-0 |
|
Acetoacetanilide, 99%
| 102-01-2 |
|
2,2-Dichloro-1,4-Butanediol, 99%
| 0-00-1 |
|
Tetra-N-Pentylcalix[4]Resorcinolarene, 97% (TLC)
| 118629-59-7 |
|
Ethyl Nipecotate, 97%
| 71962-74-8 |
|
3,5-Dimethoxy-4-Hydroxycinnamic Acid, 98%, Predominantly Trans Isomer
| 530-59-6 |
|
Trioctylpropylammonium Chloride (Pract), 95% (Titr.)
| 40739-43-3 |
|
Isonicotinic Acid, 99%
| 55-22-1 |
|
Diethyl Terephthalate, 98% (GC)
| 636-09-9 |
|
7-Methoxy-2-tetralone, 95%
| 4133-34-0 |
|
Thallic acetate, 98% (GC)
| 2570-63-0 |
|
Isobutylamine, 99%
| 78-81-9 |
|
1-(3-Chlorophenyl)Piperazine Hydrochloride ,95%(HPLC)
| 65369-76-8 |
|
cis-2-Amino-1-cyclohexanecarboxylic acid 98%
| 5691-20-3 |
|
Chloroacetic acid sodium salt, 98% (titr.)
| 3926-62-3 |
|
Pyridinium chlorochromate, 98%
| 26299-14-9 |
|
2-(Phenylsulfonyl)aniline, 99%
| 4273-98-7 |
|
2-Methylbenzylamine, 96%
| 89-93-0 |
|
(R)-(-)-Citramalic Acid, 98+%
| 6236-10-8 |
|
4-Pentenoic acid, 99%
| 591-80-0 |
|
Citraconic Acid, 99+%
| 498-23-7 |
|
Palladium hydroxide on carbon powder, 20% pd, moisture ca 50%
| 12135-22-7 |
|
n-Hexadecyl mercaptan, tech., 92%
| 2917-26-2 |
|
Methylcyclopentane, 99+%
| 96-37-7 |
|
Epiandrosterone, 99% (HP:C)
| 481-29-8 |
|
2,3,4,5,6,6-Hexachloro-2,4-Cyclohexadien-1-One,99%
| 21306-21-8 |
|
Tributyl phosphite, 94%
| 102-85-2 |
|
4-Carboxybenzenesulfonamide, 98%
| 138-41-0 |
|
Propargyltriphenylphosphonium Bromide,99+%
| 2091-46-5 |
|
N-Methylhydroxylamine hydrochloride, 98%
| 4229-44-1 |
|
D,L-2-pyrrolidone-5-carboxylic acid,98%
| 149-87-1 |
|
Peanut Oil
| 8002-03-7 |
|
Diisopropyl Azodicarboxylate, 97%
| 2446-83-5 |
|
DL-2-Pentanol
| 6032-29-7 |
|
3,4,5-Trichloroaniline, 97%
| 634-91-3 |
|
Cyanourea, Sodium Salt, 98%
| 76989-89-4 |
|
4-Chlorophenylacetic Acid, 98% (GC)
| 1878-66-6 |
|
3-Fluorophenylacetonitrile, 99+%
| 501-00-8 |
|
Decahydroquinoline, 98%, Mixture of Cis and Trans
| 2051-28-7 |
|
Diphenylmethane, P.A.
| 101-81-5 |
|
Trans 2, cis 6-Nonadienal
| 557-48-2 |
|
|